 | • レポートコード：QYR9ST08775 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、貧血治療薬の世界市場について調査・分析し、貧血治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（サプリメント、抗生物質、免疫抑制剤、骨髄刺激薬、コルチコステロイド、遺伝子治療、鉄キレート剤）、用途別（鉄欠乏性貧血、サラセミア、再生不良性貧血、溶血性貧血、鎌状赤血球貧血、悪性貧血）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の貧血治療薬市場動向 ・主要企業別マーケットシェア ・貧血治療薬の種類別市場規模2014-2019 （サプリメント、抗生物質、免疫抑制剤、骨髄刺激薬、コルチコステロイド、遺伝子治療、鉄キレート剤） ・貧血治療薬の用途別市場規模2014-2019 （鉄欠乏性貧血、サラセミア、再生不良性貧血、溶血性貧血、鎌状赤血球貧血、悪性貧血） ・貧血治療薬の北米市場：主要企業・種類別/用途別市場規模 ・貧血治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・貧血治療薬の中国市場：主要企業・種類別/用途別市場規模 ・貧血治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・貧血治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・貧血治療薬のインド市場：主要企業・種類別/用途別市場規模 ・貧血治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer, Inc.、Amgen, Inc.、Hoffmann-La Roche Ltd.、Merck Sharp & Dohme Corp.、Novartis AG、Janssen Pharmaceutical、Bayer AG、AMAG Pharmaceuticals、GlaxoSmithKline plc、Akebia Therapeutics、Vifor Pharma Management, Ltd.、FibroGen, Inc.） ・貧血治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Anemia is a condition in which you don’t have enough healthy red blood cells to carry adequate oxygen to the body’s tissues.In 2018, the global Anemia Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Anemia Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anemia Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Pfizer, Inc.
Amgen, Inc.
Hoffmann-La Roche Ltd.
Merck Sharp & Dohme Corp.
Novartis AG
Janssen Pharmaceutical
Bayer AG
AMAG Pharmaceuticals
GlaxoSmithKline plc
Akebia Therapeutics
Vifor Pharma Management, Ltd.
FibroGen, Inc.
Market segment by Type, the product can be split into
Supplements
Antibiotics
Immunosuppressant
Bone Marrow Stimulants
Corticosteroids
Gene Therapy
Iron Chelating Agents
Market segment by Application, split into
Iron deficiency anemia
Thalassemia
Aplastic anemia
Hemolytic anemia
Sickle cell anemia
Pernicious anemia
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Anemia Treatment Drugs status, future forecast, growth opportunity, key market and key players.
To present the Anemia Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Anemia Treatment Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Anemia Treatment Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Supplements
1.4.3 Antibiotics
1.4.4 Immunosuppressant
1.4.5 Bone Marrow Stimulants
1.4.6 Corticosteroids
1.4.7 Gene Therapy
1.4.8 Iron Chelating Agents
1.5 Market by Application
1.5.1 Global Anemia Treatment Drugs Market Share by Application (2019-2025)
1.5.2 Iron deficiency anemia
1.5.3 Thalassemia
1.5.4 Aplastic anemia
1.5.5 Hemolytic anemia
1.5.6 Sickle cell anemia
1.5.7 Pernicious anemia
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Anemia Treatment Drugs Market Size
2.2 Anemia Treatment Drugs Growth Trends by Regions
2.2.1 Anemia Treatment Drugs Market Size by Regions (2019-2025)
2.2.2 Anemia Treatment Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Anemia Treatment Drugs Market Size by by Players
3.1.1 Global Anemia Treatment Drugs Revenue by by Players (2014-2019)
3.1.2 Global Anemia Treatment Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Anemia Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anemia Treatment Drugs Key Players Head office and Area Served
3.3 Key Players Anemia Treatment Drugs Product/Solution/Service
3.4 Date of Enter into Anemia Treatment Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Anemia Treatment Drugs Market Size by Type (2014-2019)
4.2 Global Anemia Treatment Drugs Market Size by Application (2014-2019)
5 North America
5.1 North America Anemia Treatment Drugs Market Size (2014-2019)
5.2 Anemia Treatment Drugs Key Players in North America
5.3 North America Anemia Treatment Drugs Market Size by Type
5.4 North America Anemia Treatment Drugs Market Size by Application
6 Europe
6.1 Europe Anemia Treatment Drugs Market Size (2014-2019)
6.2 Anemia Treatment Drugs Key Players in Europe
6.3 Europe Anemia Treatment Drugs Market Size by Type
6.4 Europe Anemia Treatment Drugs Market Size by Application
7 China
7.1 China Anemia Treatment Drugs Market Size (2014-2019)
7.2 Anemia Treatment Drugs Key Players in China
7.3 China Anemia Treatment Drugs Market Size by Type
7.4 China Anemia Treatment Drugs Market Size by Application
8 Japan
8.1 Japan Anemia Treatment Drugs Market Size (2014-2019)
8.2 Anemia Treatment Drugs Key Players in Japan
8.3 Japan Anemia Treatment Drugs Market Size by Type
8.4 Japan Anemia Treatment Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Anemia Treatment Drugs Market Size (2014-2019)
9.2 Anemia Treatment Drugs Key Players in Southeast Asia
9.3 Southeast Asia Anemia Treatment Drugs Market Size by Type
9.4 Southeast Asia Anemia Treatment Drugs Market Size by Application
10 India
10.1 India Anemia Treatment Drugs Market Size (2014-2019)
10.2 Anemia Treatment Drugs Key Players in India
10.3 India Anemia Treatment Drugs Market Size by Type
10.4 India Anemia Treatment Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Anemia Treatment Drugs Market Size (2014-2019)
11.2 Anemia Treatment Drugs Key Players in Central & South America
11.3 Central & South America Anemia Treatment Drugs Market Size by Type
11.4 Central & South America Anemia Treatment Drugs Market Size by Application
12 International Players Profiles
12.1 Pfizer, Inc.
12.1.1 Pfizer, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Anemia Treatment Drugs Introduction
12.1.4 Pfizer, Inc. Revenue in Anemia Treatment Drugs Business (2014-2019))
12.1.5 Pfizer, Inc. Recent Development
12.2 Amgen, Inc.
12.2.1 Amgen, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Anemia Treatment Drugs Introduction
12.2.4 Amgen, Inc. Revenue in Anemia Treatment Drugs Business (2014-2019)
12.2.5 Amgen, Inc. Recent Development
12.3 Hoffmann-La Roche Ltd.
12.3.1 Hoffmann-La Roche Ltd. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Anemia Treatment Drugs Introduction
12.3.4 Hoffmann-La Roche Ltd. Revenue in Anemia Treatment Drugs Business (2014-2019)
12.3.5 Hoffmann-La Roche Ltd. Recent Development
12.4 Merck Sharp & Dohme Corp.
12.4.1 Merck Sharp & Dohme Corp. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Anemia Treatment Drugs Introduction
12.4.4 Merck Sharp & Dohme Corp. Revenue in Anemia Treatment Drugs Business (2014-2019)
12.4.5 Merck Sharp & Dohme Corp. Recent Development
12.5 Novartis AG
12.5.1 Novartis AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Anemia Treatment Drugs Introduction
12.5.4 Novartis AG Revenue in Anemia Treatment Drugs Business (2014-2019)
12.5.5 Novartis AG Recent Development
12.6 Janssen Pharmaceutical
12.6.1 Janssen Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Anemia Treatment Drugs Introduction
12.6.4 Janssen Pharmaceutical Revenue in Anemia Treatment Drugs Business (2014-2019)
12.6.5 Janssen Pharmaceutical Recent Development
12.7 Bayer AG
12.7.1 Bayer AG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Anemia Treatment Drugs Introduction
12.7.4 Bayer AG Revenue in Anemia Treatment Drugs Business (2014-2019)
12.7.5 Bayer AG Recent Development
12.8 AMAG Pharmaceuticals
12.8.1 AMAG Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Anemia Treatment Drugs Introduction
12.8.4 AMAG Pharmaceuticals Revenue in Anemia Treatment Drugs Business (2014-2019)
12.8.5 AMAG Pharmaceuticals Recent Development
12.9 GlaxoSmithKline plc
12.9.1 GlaxoSmithKline plc Company Details
12.9.2 Company Description and Business Overview
12.9.3 Anemia Treatment Drugs Introduction
12.9.4 GlaxoSmithKline plc Revenue in Anemia Treatment Drugs Business (2014-2019)
12.9.5 GlaxoSmithKline plc Recent Development
12.10 Akebia Therapeutics
12.10.1 Akebia Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Anemia Treatment Drugs Introduction
12.10.4 Akebia Therapeutics Revenue in Anemia Treatment Drugs Business (2014-2019)
12.10.5 Akebia Therapeutics Recent Development
12.11 Vifor Pharma Management, Ltd.
12.12 FibroGen, Inc.
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Anemia Treatment Drugs Key Market Segments
Table Key Players Anemia Treatment Drugs Covered
Table Global Anemia Treatment Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Supplements Figures
Table Key Players of Supplements
Figuer Antibiotics Figures
Table Key Players of Antibiotics
Figuer Immunosuppressant Figures
Table Key Players of Immunosuppressant
Figuer Bone Marrow Stimulants Figures
Table Key Players of Bone Marrow Stimulants
Figuer Corticosteroids Figures
Table Key Players of Corticosteroids
Figuer Gene Therapy Figures
Table Key Players of Gene Therapy
Figuer Iron Chelating Agents Figures
Table Key Players of Iron Chelating Agents
Table Global Anemia Treatment Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Anemia Treatment Drugs Market Share by Application in 2018 & 2025
Figure Iron deficiency anemia Case Studies
Figure Thalassemia Case Studies
Figure Aplastic anemia Case Studies
Figure Hemolytic anemia Case Studies
Figure Sickle cell anemia Case Studies
Figure Pernicious anemia Case Studies
Figure Anemia Treatment Drugs Report Years Considered
Figure Global Anemia Treatment Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Anemia Treatment Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Anemia Treatment Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Anemia Treatment Drugs Market Share by Regions 2014-2019
Figure Global Anemia Treatment Drugs Market Share by Regions 2014-2019
Figure Global Anemia Treatment Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Anemia Treatment Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Anemia Treatment Drugs Market Share by by Players (2014-2019)
Figure Global Anemia Treatment Drugs Market Share by by Players in 2018
Table Global Anemia Treatment Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Anemia Treatment Drugs Product/Solution/Service
Table Date of Enter into Anemia Treatment Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Anemia Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Anemia Treatment Drugs Market Size Share by Type (2014-2019)
Figure Global Anemia Treatment Drugs Market Size Market Share by Type (2014-2019)
Table Global Anemia Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Anemia Treatment Drugs Market Size Share by Application (2014-2019)
Figure Global Anemia Treatment Drugs Market Size Market Share by Application (2014-2019)
Figure Global Anemia Treatment Drugs Revenue Market Share by Application in 2018
Figure North America Anemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Anemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Anemia Treatment Drugs Market Share (2018-2019)
Table North America Anemia Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Anemia Treatment Drugs Market Share by Type 2014-2019
Table North America Anemia Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Anemia Treatment Drugs Market Share by Application 2014-2019
Figure Europe Anemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Anemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Anemia Treatment Drugs Market Share (2018-2019)
Table Europe Anemia Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Anemia Treatment Drugs Market Share by Type 2014-2019
Table Europe Anemia Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Anemia Treatment Drugs Market Share by Application 2014-2019
Figure China Anemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Anemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Anemia Treatment Drugs Market Share (2018-2019)
Table China Anemia Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table China Anemia Treatment Drugs Market Share by Type 2014-2019
Table China Anemia Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table China Anemia Treatment Drugs Market Share by Application 2014-2019
Figure Japan Anemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Anemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Anemia Treatment Drugs Market Share (2018-2019)
Table Japan Anemia Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Anemia Treatment Drugs Market Share by Type 2014-2019
Table Japan Anemia Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Anemia Treatment Drugs Market Share by Application 2014-2019
Figure Southeast Asia Anemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Anemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Anemia Treatment Drugs Market Share (2018-2019)
Table Southeast Asia Anemia Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Anemia Treatment Drugs Market Share by Type 2014-2019
Table Southeast Asia Anemia Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Anemia Treatment Drugs Market Share by Application 2014-2019
Figure India Anemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Anemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Anemia Treatment Drugs Market Share (2018-2019)
Table India Anemia Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table India Anemia Treatment Drugs Market Share by Type 2014-2019
Table India Anemia Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table India Anemia Treatment Drugs Market Share by Application 2014-2019
Figure Central & South America Anemia Treatment Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Anemia Treatment Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Anemia Treatment Drugs Market Share (2018-2019)
Table Central & South America Anemia Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Anemia Treatment Drugs Market Share by Type 2014-2019
Table Central & South America Anemia Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Anemia Treatment Drugs Market Share by Application 2014-2019
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Revenue in Anemia Treatment Drugs Business 2014-2019 (Million US$)
Figure Pfizer, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2014-2019)
Table Pfizer, Inc. Recent Development
Table Amgen, Inc. Company Details
Table Amgen, Inc. Revenue in Anemia Treatment Drugs Business 2014-2019 (Million US$)
Figure Amgen, Inc. Revenue Growth Rate in Anemia Treatment Drugs Business (2014-2019)
Table Amgen, Inc. Recent Development
Table Hoffmann-La Roche Ltd. Company Details
Table Hoffmann-La Roche Ltd. Revenue in Anemia Treatment Drugs Business 2014-2019 (Million US$)
Figure Hoffmann-La Roche Ltd. Revenue Growth Rate in Anemia Treatment Drugs Business (2014-2019)
Table Hoffmann-La Roche Ltd. Recent Development
Table Merck Sharp & Dohme Corp. Company Details
Table Merck Sharp & Dohme Corp. Revenue in Anemia Treatment Drugs Business 2014-2019 (Million US$)
Figure Merck Sharp & Dohme Corp. Revenue Growth Rate in Anemia Treatment Drugs Business (2014-2019)
Table Merck Sharp & Dohme Corp. Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Anemia Treatment Drugs Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Anemia Treatment Drugs Business (2014-2019)
Table Novartis AG Recent Development
Table Janssen Pharmaceutical Company Details
Table Janssen Pharmaceutical Revenue in Anemia Treatment Drugs Business 2014-2019 (Million US$)
Figure Janssen Pharmaceutical Revenue Growth Rate in Anemia Treatment Drugs Business (2014-2019)
Table Janssen Pharmaceutical Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Anemia Treatment Drugs Business 2014-2019 (Million US$)
Figure Bayer AG Revenue Growth Rate in Anemia Treatment Drugs Business (2014-2019)
Table Bayer AG Recent Development
Table AMAG Pharmaceuticals Company Details
Table AMAG Pharmaceuticals Revenue in Anemia Treatment Drugs Business 2014-2019 (Million US$)
Figure AMAG Pharmaceuticals Revenue Growth Rate in Anemia Treatment Drugs Business (2014-2019)
Table AMAG Pharmaceuticals Recent Development
Table GlaxoSmithKline plc Company Details
Table GlaxoSmithKline plc Revenue in Anemia Treatment Drugs Business 2014-2019 (Million US$)
Figure GlaxoSmithKline plc Revenue Growth Rate in Anemia Treatment Drugs Business (2014-2019)
Table GlaxoSmithKline plc Recent Development
Table Akebia Therapeutics Company Details
Table Akebia Therapeutics Revenue in Anemia Treatment Drugs Business 2014-2019 (Million US$)
Figure Akebia Therapeutics Revenue Growth Rate in Anemia Treatment Drugs Business (2014-2019)
Table Akebia Therapeutics Recent Development
Table Vifor Pharma Management, Ltd. Company Details
Table FibroGen, Inc. Company Details
Table Global Anemia Treatment Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Anemia Treatment Drugs Market Size Share by Regions (2019-2025)
Figure Global Anemia Treatment Drugs Market Size Share by Regions in 2025
Figure North America Anemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Anemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Anemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Anemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Anemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Anemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Anemia Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Anemia Treatment Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Anemia Treatment Drugs Market Size by Product (2019-2025)
Figure Global Anemia Treatment Drugs Market Size by Product in 2025
Table Global Anemia Treatment Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Anemia Treatment Drugs Market Size by Application (2019-2025)
Figure Global Anemia Treatment Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
鎌状赤血球貧血治療の世界市場：市場規模・現状・予測 Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…- 世界の腎性貧血治療市場：専門的調査 Anemia is a common complication of CKD, typically occurring early in the development of the disease and becoming more severe as CKD progresses. The primary treatment goal in renal anemia is to increase and maintain hemoglobin and other anemia parameters, such as ferritin. The global Renal Anemia Tre…
- 貧血治療薬の世界市場：市場規模・現状・予測 Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia.The iron deficiency anemia market segment accounted for the …
- 鎌状赤血球貧血治療法の世界市場：市場規模・現状・予測 Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…
- 世界の鎌状赤血球貧血治療法市場：動向・競争分析 Sickle cell anemia is an inherited form of anemia — a condition in which there aren't enough healthy red blood cells to carry adequate oxygen throughout your body.In 2018, the global Sickle Cell Anemia Therapeutics market size was xx million US$ and is forecast to xx million US in 2025, growing at a…